about
Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic DisordersGut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of MetabolomicsThe interplay between intestinal bacteria and host metabolism in health and disease: lessons from Drosophila melanogasterGrowing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and BehaviorProbiotics in prevention and treatment of obesity: a critical viewPathogenic Microorganisms and Pancreatic CancerThe role of fatty acids in insulin resistanceHuman microbiome: From the bathroom to the bedsideCan probiotics benefit children with autism spectrum disorders?Treating Obesity and Metabolic Syndrome with Fecal Microbiota TransplantationMaternal Microbiome and Pregnancy Outcomes That Impact Infant Health: A ReviewGut Microbiome and Obesity: A Plausible Explanation for ObesityAutoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feelingProkaryotes Versus Eukaryotes: Who is Hosting Whom?Anti-obesogenic and antidiabetic effects of plants and mushrooms.Gut microbioma population: an indicator really sensible to any change in age, diet, metabolic syndrome, and life-style.Obesity and diabetes: from genetics to epigenetics.Diet, microbiota, and dysbiosis: a 'recipe' for colorectal cancer.Future Perspectives of Personalized Weight Loss Interventions Based on Nutrigenetic, Epigenetic, and Metagenomic Data.The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes.Caecal pH is a biomarker of excessive colonic fermentation.Association between prehypertension, metabolic and inflammatory markers, decreased adiponectin and enhanced insulinemia in obese subjects.Microbiome Remodeling via the Montmorillonite Adsorption-Excretion Axis Prevents Obesity-related Metabolic Disorders.Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approachesThe risk of colonic adenomas and colonic cancer in obesityThe health advantage of a vegan diet: exploring the gut microbiota connection.Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications.Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulationGut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.The Gordian Knot of dysbiosis, obesity and NAFLD.The pathophysiology of hypertension in patients with obesity.Diet effects in gut microbiome and obesity.The gastrointestinal microbiota and colorectal cancer.Changes in mouse gastrointestinal microbial ecology with ingestion of kale.Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.Anti-obesity activity of the marine carotenoid fucoxanthin.Contrasting effects of fresh and fermented kimchi consumption on gut microbiota composition and gene expression related to metabolic syndrome in obese Korean women.Gut microbiota: a key player in health and disease. A review focused on obesity.Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain.
P2860
Q26752979-8FB2CD1B-7B47-4EB2-AF82-AA84F6C740B6Q26753047-FFB4ED8A-8139-4CE7-BE83-68072CE979A1Q26765013-E787E26A-B245-433C-AEC5-D8A3A52A5462Q26766519-BE97B4C7-7CCF-4986-B246-6F8113F0BDA8Q26768518-707D0E0D-C409-4735-8CD2-A7A54D189797Q26775596-0A81C3CB-1E9A-49C3-B703-F89A9D6CE18EQ26785440-0087C5EA-28DD-4164-AE9E-4CD7E55D2F33Q26795386-7D59FF12-1DCD-4172-B2C8-142D68C26BCDQ28076833-B13AC31A-8337-4494-BDD2-BC98618771EEQ28078234-BAB33F8E-02C1-4BEE-AFD8-8FDFF4EDBAE9Q28085574-9AD5032D-7256-4CCF-86C8-579D74FBB4ECQ28087145-E646EF4D-BE03-42B2-B109-1A220BA7A85CQ28244133-32C38D6C-CFE5-47C4-8852-7BD6FB19EE20Q28606744-3CF264DB-7606-4473-8D75-6F66A2B971D6Q30241950-E19657D9-07DD-47D0-AA36-B13EA2705230Q30364423-377EB509-C553-44B1-80C2-3261C3A9FAEFQ30367134-AA530295-DE45-4150-B12D-F8F6389CCD90Q30384134-F6A6E346-DE64-45D7-AC1A-2D68054670A8Q31056421-B35C8857-A8A4-43F9-B3B9-7B68AFE08D93Q31141977-9B91A270-44AF-421D-B4F1-0C0E0D1FD18BQ33564151-1123C397-773D-4F12-B2D4-79D71179B239Q33803656-69E3C566-8C3C-4BBB-8601-07EFFDF64AC9Q33809487-C5D8E16C-55BC-4394-9A13-522048C89C0AQ34114026-81DFA4E2-2AA1-4CD7-96BD-F5A9E8EA27C3Q34157499-2A1F889C-12AE-4E76-A7C3-74FD37962065Q34446013-7729922A-C916-43BC-B40C-4C6700AF793FQ34499017-4F367943-B561-425E-85B6-56FDD9A9B824Q34589700-628B324E-E9DA-460F-B04A-8485C1BC2867Q34669782-2FF783B7-68DB-4A85-88EE-10550E716D82Q34866320-61D8182D-465F-497E-8DF6-0C44DEEACC8EQ34956813-60CA9AE2-F063-4B5F-9BEC-7FD7DCACCE93Q35021492-42288EC8-73C5-4202-B0B1-1AA835DAF35DQ35118425-ABEB2604-F9FC-4981-9AA1-71134A903A9AQ35138535-71245166-C060-4EEB-A7BC-0A5896878D36Q35148911-2D079A14-3ED0-4EF1-9A82-9B5C5FE41C14Q35373283-0B6CC0AA-BE3A-4E93-9C5F-608CCC406C98Q35548885-5BEF6782-27ED-454A-8827-2865FCC2AE48Q35562538-12F72E1A-C648-4540-BC0D-53FC8CC883FFQ35573445-38F14973-16D1-40F4-8ABE-DD7C7C4D41C5Q35602080-83CC800A-6AD8-4851-8C39-4336F3475C96
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The gut microbiota, obesity and insulin resistance.
@en
type
label
The gut microbiota, obesity and insulin resistance.
@en
prefLabel
The gut microbiota, obesity and insulin resistance.
@en
P2093
P1476
The gut microbiota, obesity and insulin resistance.
@en
P2093
Liping Zhao
Martin S Obin
P356
10.1016/J.MAM.2012.11.001
P577
2012-11-16T00:00:00Z